Westchester Capital Management (New York)’s Psyence Biomedical Warrant PBMWW Stock Holding History

Westchester Capital Management (New York)’s Portfolio PBMWW Stock Details PBMWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-92,073	Closed	-$2.3K	–	314
2025 Q3	$2.3K	Hold	92,073	–	–	﹤0.01%	256
2025 Q2	$1.86K	Hold	92,073	–	–	﹤0.01%	209
2025 Q1	$1.56K	Hold	92,073	–	–	﹤0.01%	170
2024 Q4	$1.13K	Hold	92,073	–	–	﹤0.01%	164
2024 Q3	$1.17K	Hold	92,073	–	–	﹤0.01%	186
2024 Q2	$976	Hold	92,073	–	–	﹤0.01%	222
2024 Q1	$6.59K	Buy	+92,073	New	+$5.74K	﹤0.01%	225

Other funds holding PBMWW

HCI

Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Westchester Capital Management (New York)'s PBMWW Position: Q4 2025 in Review

Westchester Capital Management (New York) sold out of Psyence Biomedical Warrant (PBMWW) in Q4 2025, closing a stake of 92,073 shares — an estimated $2.3K sold.

Westchester Capital Management (New York) first reported a position in PBMWW in Q1 2024 and held it in 7 quarters. The position peaked at $6.59K in Q1 2024. 21 funds tracked by Wall St. Rank hold PBMWW as of Q4 2025.

Westchester Capital Management (New York) reported no remaining Psyence Biomedical Warrant position as of Q4 2025 after selling out during the quarter.
Westchester Capital Management (New York) sold 92,073 Psyence Biomedical Warrant shares in Q4 2025, an estimated $2.3K.
Westchester Capital Management (New York) first reported a position in Psyence Biomedical Warrant in Q1 2024 and held it in 7 quarters.
Westchester Capital Management (New York)'s Psyence Biomedical Warrant position peaked at $6.59K in Q1 2024.
21 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q4 2025.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.